相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evodiamine Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in BV-2 Cells via Regulating AKT/Nrf2-HO-1/NF-κB Signaling Axis
Tianyu Meng et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)
Treatment of Neurodegenerative Diseases with Bioactive Components of Tripterygium wilfordii
Jianheng Li et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
Tackling Alzheimer's disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents
Mateusz Luc et al.
LIFE SCIENCES (2019)
Current and Future Treatments in Alzheimer's Disease
Alireza Atri
SEMINARS IN NEUROLOGY (2019)
Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimer's Disease
Lavida R. K. Brooks et al.
FRONTIERS IN NEUROSCIENCE (2019)
Benefits of curcumin in brain disorders
Abid Bhat et al.
BIOFACTORS (2019)
Classification of alkaloids according to the starting substances of their biosynthetic pathways using graph convolutional neural networks
Ryohei Eguchi et al.
BMC BIOINFORMATICS (2019)
Red Ginseng Attenuates Aβ-Induced Mitochondrial Dysfunction and Aβ-mediated Pathology in an Animal Model of Alzheimer's Disease
Soo Jung Shin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Neuroimaging Biomarkers for Alzheimer's Disease
Freddie Marquez et al.
MOLECULAR NEURODEGENERATION (2019)
Effects of Tianshu Capsule on Spontaneously Hypertensive Rats as Revealed by 1H-NMR-Based Metabolic Profiling
Jian Gao et al.
FRONTIERS IN PHARMACOLOGY (2019)
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
Ganesh M. Babulal et al.
ALZHEIMERS & DEMENTIA (2019)
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
Caiyan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Biomarkers for the diagnosis of Alzheimer's disease, dementia Lewy body, frontotemporal dementia and vascular dementia
Joshua Marvin Anthony Maclin et al.
GENERAL PSYCHIATRY (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Evodiamine Reduces Caffeine-Induced Sleep Disturbances and Excitation in Mice
Yong-Hyun Ko et al.
BIOMOLECULES & THERAPEUTICS (2018)
Perceptions of traditional Chinese medicine for chronic disease care and prevention: a cross-sectional study of Chinese hospital-based health care professionals
Xiaoqing Fan et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease
Liang Feng et al.
BMC NEUROLOGY (2018)
Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients
Jade M. Kozuch et al.
CLINICAL TRANSPLANTATION (2018)
Protective effects of evodiamine in experimental paradigm of Alzheimer's disease
Dongmei Wang et al.
COGNITIVE NEURODYNAMICS (2018)
Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting beta/gamma-Secretases Activity and Enhancing alpha-Secretases
Zhiyou Cai et al.
CURRENT ALZHEIMER RESEARCH (2018)
Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats
Hend M. Hussien et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease Three Randomized Clinical Trials
Alireza Atri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease
Atish Kumar Sahoo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
BACE1 Inhibition by Genistein: Biological Evaluation, Kinetic Analysis, and Molecular Docking Simulation
Kumju Youn et al.
JOURNAL OF MEDICINAL FOOD (2018)
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
Ilijana Begcevic et al.
JOURNAL OF PROTEOMICS (2018)
Qi Fu Yin-a Ming Dynasty Prescription for the Treatment of Dementia
Wei-Yi Ong et al.
MOLECULAR NEUROBIOLOGY (2018)
Muscarinic receptor oligomerization
Sara Marsango et al.
NEUROPHARMACOLOGY (2018)
Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's disease
Francesco Maione et al.
PHARMACOLOGICAL RESEARCH (2018)
Berberine: Pathways to protect neurons
Xiaorui Lin et al.
PHYTOTHERAPY RESEARCH (2018)
Alzheimer disease pathology and the cerebrospinal fluid proteome
Loic Dayon et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
In vivo Imaging of Glial Activation in Alzheimer's Disease
Paul Edison et al.
FRONTIERS IN NEUROLOGY (2018)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team
Stephen P. Arneric et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease
Lan Guo et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Mouse Models of Alzheimer's Disease
Gisela Esquerda-Canals et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease
Ugur Damar et al.
MEDICAL HYPOTHESES (2017)
Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase
Haijing Zhang et al.
NEUROPHARMACOLOGY (2017)
Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation
Wenbo He et al.
PHARMACOLOGICAL REPORTS (2017)
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
Gargi Ganguly et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Rhizoma Coptidis and Berberine as a Natural Drug to Combat Aging and Aging-Related Diseases via Anti-Oxidation and AMPK Activation
Zhifang Xu et al.
AGING AND DISEASE (2017)
Cytosolic Abnormally Hyperphosphorylated Tau But Not Paired Helical Filaments Sequester Normal MAPs and Inhibit Microtubule Assembly
Khalid Iqbal et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Non-random transmission of parental alleles into crop-wild and crop-weed hybrid lineages separated by a transgene and neutral identifiers in rice
Zhe Wang et al.
SCIENTIFIC REPORTS (2017)
Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer's disease: a retrospective analysis
Jing Shi et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease
Fang Du et al.
BRAIN (2017)
Integration of nano drug-delivery system with cancer immunotherapy
Takashi Nakamura et al.
THERAPEUTIC DELIVERY (2017)
Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review
Yingying Jiang et al.
BIOORGANIC CHEMISTRY (2017)
Molecular Pathogenesis of Alzheimer's Disease: An Update
Alfredo Sanabria-Castro et al.
ANNALS OF NEUROSCIENCES (2017)
Opportunities and challenges in developing relevant animal models for Alzheimer's disease
Fernanda G. De Felice et al.
AGEING RESEARCH REVIEWS (2016)
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A. Gordon et al.
BRAIN (2016)
Mitochondrial Respiration in the Platelets of Patients with Alzheimer's Disease
Zdenek Fisar et al.
CURRENT ALZHEIMER RESEARCH (2016)
Alkaloids Pharmacological Activities - Prospects for the Development of Phytopharmaceuticals for Neurodegenerative Diseases
Soane K. M. Chaves et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
Research progress on berberine with a special focus on its oral bioavailability
Chang-Shun Liu et al.
FITOTERAPIA (2016)
Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death
Juliana Sorraila de Oliveira et al.
NEUROTOXICOLOGY (2016)
Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies
Isaac G. Onyango et al.
AGING AND DISEASE (2016)
Targeting neuroinflammation in Alzheimer's disease
Maria Rosanna Bronzuoli et al.
JOURNAL OF INFLAMMATION RESEARCH (2016)
Baicalein improves behavioral dysfunction induced by Alzheimer's disease in rats
Li Zhou et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Role of berberine in Alzheimer's disease
Zhiyou Cai et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?
Megan J. Ehret et al.
CLINICAL THERAPEUTICS (2015)
Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation
Li-Hua Sun et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Therapeutic potential of berberine against neurodegenerative diseases
Jiang WenXiao et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease
Cole Schaffer et al.
JALA (2015)
Methanolic Extract of Piper nigrum Fruits Improves Memory Impairment by Decreasing Brain Oxidative Stress in Amyloid Beta(1-42) Rat Model of Alzheimer's Disease
Lucian Hritcu et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
In Search of Antiaging Modalities: Evaluation of mTOR- and ROS/ DNA Damage-Signaling by Cytometry
Zbigniew Darzynkiewicz et al.
CYTOMETRY PART A (2014)
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine
Guozheng Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Isorhynchophylline Treatment Improves the Amyloid-beta-Induced Cognitive Impairment in Rats via Inhibition of Neuronal Apoptosis and Tau Protein Hyperphosphorylation
Yan-Fang Xian et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
Shichun Tu et al.
MOLECULAR NEURODEGENERATION (2014)
Dysfunctional mitochondrial bioenergetics and oxidative stress in Akita+/Ins2-derived β-cells
Tanecia Mitchell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons
Tao Luo et al.
CNS & Neurological Disorders-Drug Targets (2013)
[11C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches
Zhangjie Su et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt
Yu-Shuang Chai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease
Weiyang Tao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Pharmacological Actions of Multi-Target-Directed Evodiamine
Hui Yu et al.
MOLECULES (2013)
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2013)
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
G. Chetelat et al.
REVUE NEUROLOGIQUE (2013)
Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: Up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability
Xiaolin Zhang et al.
BRAIN RESEARCH (2012)
PI3K p55γ promoter activity enhancement is involved in the anti-apoptotic effect of berberine against cerebral ischemia-reperfusion
Jun Hu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
David R. Owen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood
Anders Lönneborg
Molecular Diagnosis & Therapy (2012)
Steroidal alkaloids from Holarrhena antidysenterica as acetylcholinesterase inhibitors and the investigation for structure-activity relationships
Zhong-Duo Yang et al.
LIFE SCIENCES (2012)
Evodiamine improves congnitive abilities in SAMP8 and APPswe/PS1ΔE9 transgenic mouse models of Alzheimer's disease
Shu-min Yuan et al.
ACTA PHARMACOLOGICA SINICA (2011)
Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells
Feiqi Zhu et al.
BMC NEUROSCIENCE (2011)
Therapeutic Potential of Nucleic Acid-Binding Isoquinoline Alkaloids: Binding Aspects and Implications for Drug Design
Kakali Bhadra et al.
MEDICINAL RESEARCH REVIEWS (2011)
Brain fuel metabolism, aging, and Alzheimer's disease
Stephen Cunnane et al.
NUTRITION (2011)
Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components
Jyh-Fei Liao et al.
CHINESE MEDICINE (2011)
Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities
Zha-Jun Zhan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Herbal therapy: a new pathway for the treatment of Alzheimer's disease
Jinzhou Tian et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
AMPKα1 regulates the antioxidant status of vascular endothelial cells
Sergio L. Colombo et al.
BIOCHEMICAL JOURNAL (2009)
Berberine Exerts Neuroprotective Actions against in Vitro Ischemia-Induced Neuronal Cell Damage in Organotypic Hippocampal Slice Cultures: Involvement of B-Cell Lymphoma 2 Phosphorylation Suppression
Hu-Shan Cui et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Progress in the studies on rutaecarpine
Seung Ho Lee et al.
MOLECULES (2008)
Glial regulation of the cerebral microvasculature
Costantino Iadecola et al.
NATURE NEUROSCIENCE (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders
V Papadopoulos et al.
NEUROSCIENCE (2006)
Acetylcholinesterase inhibitors from plants and fungi
PJ Houghton et al.
NATURAL PRODUCT REPORTS (2006)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver
VM Rodríguez et al.
TOXICOLOGICAL SCIENCES (2005)
Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38δ at Thr50 promotes microtubule assembly
C Feijoo et al.
JOURNAL OF CELL SCIENCE (2005)
Cholinesterase inhibitors: new roles and therapeutic alternatives
E Giacobini
PHARMACOLOGICAL RESEARCH (2004)
Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression
YK Li et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
